In recent days, two U.S. pharmaceutical companies announced that their COVID-19 vaccines could be available by December. U.S.-based Pfizer, who partnered with the German-based BioNTech, said it has a 95 percent success rate during clinical trials....
![Foreign Correspondent: The Upcoming Fights Over COVID-19 Vaccines](https://mlzxwac42xdq.i.optimole.com/w:1080/h:675/q:mauto/rt:fill/g:ce/f:best/https://www.parkindymedia.org/wp-content/uploads/2020/11/2020-Laboratory-Careers.jpg)